MMP-2 gelatinase A GL, Col I, IV, V, VII, X, XI, EL, MMP-9 gelatinase B FN, LN, LP, AG, galectin-3, IGF-BP, VN, FGF receptor-1, Figure 1 . Cell Surface Activation of Progelatinase A by MT1-MMP Pro-MMP-2, -9, -13
The zymogen (pro)form of the transmembrane MT1-MMP is acti-MMP-3 stromelysin-1 PG, LN, FN, GL, Col III, IV, vated by proteolysis, either in the Golgi by a furin family proteinase MMP-10 stromelysin-2 V, IX, X, XI, LP, FB, EN, TN, VN, or on the cell surface by a proteinase such as plasmin. The activated MMP-7 matrilysin Pro-MMP-1, -8, -9, -13, ␣1PI, MT1-MMP then binds the inhibitor TIMP-2 by its N-terminal inhibi-␣2M, L-selectin tory domain. tion (Coussens and Werb, 1996) . Proteinases mediate Programmed cell death also regulates neuronal coma Substrates are grouped for similar enzymes, but not all of the munication, both during development and in disease proteins in each group are cleaved by all the enzymes in the group.
processes. In the hippocampus tPA participates in neuronal plasticity. Plasmin generated by tPA induces neuronal cell death (Tsirka et al., 1997 , and references The enzymes that cleave the N-and C-terminal propeptides of the fibrillar collagens during collagen assemtherein), probably through degradation of ECM molecules that are essential for neuronal survival in culture. bly have long been sought. The surprising discovery that BMP1 cleaves the C-terminal propeptide of type I
The excitotoxin-stimulated neurons no longer die in animals null for tPA. collagen supports the original finding that a metalloenzyme is involved. BMP1, which was isolated as an Interestingly, in both mammary gland and brain, the proteinases are expressed by the supporting cells (stroinducer of bone formation, is related to tld, which activates decapentaplegic, a member of the TGF␤ supermal or microglial), not by the epithelial or neuronal cells that die. Thus, apoptosis is an example of cell-to-cell family that specifies the dorsal-ventral axis in Drosophila. Mouse embryos with homozygous deletions in the communication, with ECM proteinases as the mediators. However, the cleavage of ECM components can BMP1/tld gene develop until late gestation with few morphologic defects, but have abnormal collagen fibrils and also enhance viability of cells by the generation of bioactive fragments of ECM proteins or release of cytokines. die at birth (Suzuki et al., 1996 , and references therein). However, mutations in tld in Drosophila have severe
In the case for melanoma cells, degradation of collagen promotes survival by liberating fragments recognized developmental consequences. This opens up the possibility that ECM proteinases important in mammalian emby ␣v␤3 integrin (Varner and Cheresh, 1996) . ECM Proteolysis and Neoplastic Transformation bryogenesis still remain to be discovered.
ECM Proteolysis and Regulation of Apoptosis
ECM-degrading MMPs, uPA, and other proteinases are universally expressed during tumor progression and ECM provides adhesive signals that control cell viability. Degradation of ECM is the most effective mechanism metastasis (Coussens and Werb, 1996; Andreasen et al., 1997). The majority of proteinases are made by the L-selectin, the apoptosis inducer Fas ligand, TGF␣, and the IL-6 receptor, is mediated by enzymes that may responding stroma of epithelial tumors. The enzymes be distinct from TACE. ECM proteinases may be as can then bind to the surface of tumor cells. Whether or important as regulators of cytokine function, epithelial how these proteinases are involved in angiogenesis, barrier function, or antimicrobial activity, as they are in tumor initiation, growth, metastasis, or in the host de-ECM proteolysis. fense against the tumor remains to be determined.
Extracellular Proteolysis and Signal Transduction Most commonly, proteinases facilitate tumor progres-
During cellular responses to developmental and pathosion. Proteinases may act on ECM to free cells from logic cues, ECM, cell surface proteins, and receptors ECM-induced cell cycle arrest, facilitate dedifferentiaare activated or removed by proteolysis. Just as protein tion, mediate invasion, or release latent growth/angiomodification by phosphorylation is an effective means genesis factors (Coussens and Werb, 1996) . Blocking of intracellular signal transduction, protein modification function of ECM proteinases can decrease tumor growth by proteolysis, by virtue of its irreversible nature, is ide- (Martin et al., 1997; Wilson et al., 1997) , while their ecally suited to regulate extracellular signal transduction topic expression can increase carcinogenic potential, in the pericellular environment and thus to push forward indicating that they contribute to the neoplastic process.
the unidirectional decisions of development and disease However, proteinases also may inhibit tumorigenesis by (Figure 2) . inducing apoptosis or by releasing latent angiogenesis
The prototype for such signaling is the protease-actiinhibitors from ECM proteins.
vated receptor (PAR) family, which encode blocked, Pericellular Proteolysis and Immunity tethered ligands (Ishihara et al., 1997 , and references One overlooked aspect of pericellular proteolysis is its therein). Thrombin cleaves PAR-1 or PAR-3, initiating a potential role in immunity and host defense. ECM pro-G protein-coupled cascade that can regulate fibroblast teolytic cascades resemble those of complement activaproliferation or neuronal survival. PAR-2 activation by tion and coagulation, and macrophages and other intryptase released by mast cells may underlie increased flammatory cells involved in the innate immune response collagen I synthesis by fibroblasts (Cairns and Walls, express many ECM proteinases (Andreasen et al., 1997; , and references therein) seen in fibrosis, inflammaShapiro, 1997). That extracellular proteinases regulate tion, and neoplastic progression. The binding of uPA to host defense through effects on migration or processing uPA-R is a distinct paradigm. uPA induces interaction of cytokines, complement, or fibrin, is suggested by deof uPA-R with ␤1 and ␤2 integrins, thereby regulating creased response of macrophages to inflammatory stimuli adhesion and signaling. Although bound uPA is active, in metalloelastase-deficient mice and increased susits activity is not required for signaling (Andreasen et ceptibility of uPA-deficient mice to infection. Moreover, al., 1997) . Whether similar signaling takes place for other matrilysin, which is secreted luminally in epithelia, is interactions of MMPs or ADAMs with their receptors critically placed to activate the antimicrobial cryptidins.
remains to be determined. TNF␣, a potent mediator of inflammation, is syntheADAMs, which can process or remove the extracellusized as a transmembrane molecule that can bind to lar domains of cell surface proteins, are critically placed its receptor by cell-cell contact. It is processed by profor regulating signaling (Blobel, 1997) . Indeed, Kuz proteolysis to a soluble homotrimer by TACE (Blobel, cesses Notch so that it is competent for signaling in 1997). Shedding of other cell surface molecules involved development. It is intriguing that the extracellular domain of Notch 4 is deleted in the constitutively active, in innate immunity, including the adhesion molecule
